Evidence map›Paper›PMID 42197300›Full record

ReviewMolecules (Basel, Switzerland)2026

Molecular and Analytical Understanding of Resveratrol Interactions for Advanced Biotechnological Applications.

Mohamed Brahmi, Sara Moumnassi, Adem Gharsallaoui

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mohamed BrahmiUniversité Lyon 1, CNRS, LAGEPP, UMR 5007, 01000 Bourg-en-Bresse, France.ORCID 0000-0002-0230-4492
Sara MoumnassiUniversité Lyon 1, CNRS, LAGEPP, UMR 5007, 01000 Bourg-en-Bresse, France.ORCID 0009-0009-7363-2571
Adem GharsallaouiUniversité Lyon 1, CNRS, LAGEPP, UMR 5007, 01000 Bourg-en-Bresse, France.ORCID 0000-0001-6000-1994

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Interactions between resveratrol and biological or carrier systems play a key role in determining its bioavailability, stability, and delivery performance. These interactions involve proteins, lipids, cyclodextrins, nucleic acids, polysaccharides, and other formulation matrices, and are governed by noncovalent forces such as hydrogen bonding, hydrophobic interactions, π-π stacking, and desolvation effects. This review examines how complementary spectroscopic, calorimetric, structural, and computational techniques are used to characterize resveratrol interactions. Fluorescence, UV-visible spectroscopy, circular dichroism, FTIR, NMR, ITC, DSC, X-ray diffraction, molecular docking, and molecular dynamics simulations are discussed according to their contribution to binding analysis, conformational assessment, thermodynamic interpretation, structural organization, and complex stability. By integrating these approaches, this review provides a technique-oriented framework for understanding resveratrol binding and guiding the development of more stable resveratrol-based carrier systems and bioactive formulations.

Indexed as

BiotechnologyResveratrolMolecular Docking SimulationMolecular Dynamics SimulationThermodynamicsResveratrolanalytical characterizationbioavailabilitybiotechnological applicationscalorimetric analysiscarrier systemscomputational biophysicsmolecular modellingpolyphenol-protein interactionsspectroscopic techniques

Identifiers

PMID42197300
PMCPMC13210169

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.